Nowak P, Mueller T C, Schröder R. "一种托法替布杂质67的合成方法" [P]. European Patent, EP 3515125 A1, 2021-07-13.
Kumar R, Patel M V, Chen K W. "Method for the Synthesis of Tofacitinib Impurity 67" [P]. US Patent, US 11431732 B2, 2019-12-16.
发明人唐晓军,陈志强,胡光. "A Process for Preparing High-Purity Tofacitinib Impurity 67" [P]. 中国发明专利, 专利号 CN 111128533 A, 授权公告日 2024-12-03.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 托法替布杂质67 in Pharmaceutical Formulations". J. Sep. Sci., 2017, 2079, 5915-5934.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托法替布杂质67 as an Impurity". J. Nat. Prod., 2025, 451, 3653-3656.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Tofacitinib Impurity 67 Using HRMS and NMR". Anal. Methods, 2010, 129, (4), 6975-7004.